Euclises Pharmaceuticals
St Louis
About Euclises Pharmaceuticals
Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.4M
- Last round: Series Unknown (Dec 2016)
- Website: euclises.com
- Phone: 314-604-2850
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/euclises-pharmaceuticals-9787 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.